Ribociclib-induced Vitiligo: a Case Report

被引:5
作者
Silvestre Torner, Nicolas [1 ]
Aguilar Martinez, Antonio [1 ]
Echarri Gonzalez, Maria Jose [2 ]
Carrascosa, Sergio Tabbara [1 ]
Tabbara Carrascosa, Sergio [1 ]
Roman Sainz, Jorge [1 ]
Velasco, Fernando Gruber [1 ]
机构
[1] Hosp Univ Severo Ochoa, Dept Dermatol, Ave Orellana, Leganes 28911, Madrid, Spain
[2] Hosp Univ Severo Ochoa, Dept Oncol, Leganes, Madrid, Spain
来源
DERMATOLOGY PRACTICAL & CONCEPTUAL | 2022年 / 12卷 / 02期
关键词
vitiligo; ribociclib; selective cyclin-dependent kinase 4/6 inhibitors; breast cancer; adverse event;
D O I
10.5826/dpc.1202a45
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:2
相关论文
共 2 条
  • [1] Ribociclib in HR+/HER2-Advanced or Metastatic Breast Cancer Patients
    Rascon, Kaitlin
    Flajc, Goran
    De Angelis, Carmine
    Liu, Xinli
    Trivedi, Meghana V.
    Ekinci, Ekim
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (05) : 501 - 509
  • [2] Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
    Sollena, Pietro
    Nikolaou, Vasiliki
    Soupos, Nikolaos
    Kotteas, Elias
    Voudouri, Dimitra
    Stratigos, Alexandros J.
    Fattore, Davide
    Annunziata, Maria Carmela
    Orlandi, Armando
    Di Nardo, Lucia
    Apalla, Zoe
    Deilhes, Florian
    Romano, Maria Concetta
    Fabbrocini, Gabriella
    Sibaud, Vincent
    Peris, Ketty
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 247 - 253